- Home
- BRAG vs SLGL Comparison
BRAG vs SLGL Comparison
Compare BRAG & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRAG
- SLGL
- Stock Information
- Founded
- BRAG 2018
- SLGL 1997
- Country
- BRAG Canada
- SLGL Israel
- Employees
- BRAG N/A
- SLGL N/A
- Industry
- BRAG Office Equipment/Supplies/Services
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- BRAG Technology
- SLGL Health Care
- Exchange
- BRAG Nasdaq
- SLGL Nasdaq
- Market Cap
- BRAG 74.8M
- SLGL 69.1M
- IPO Year
- BRAG N/A
- SLGL 2018
- Fundamental
- Price
- BRAG $2.89
- SLGL $39.05
- Analyst Decision
- BRAG Buy
- SLGL
- Analyst Count
- BRAG 4
- SLGL 0
- Target Price
- BRAG $7.00
- SLGL N/A
- AVG Volume (30 Days)
- BRAG 62.4K
- SLGL 20.4K
- Earning Date
- BRAG 11-13-2025
- SLGL 11-14-2025
- Dividend Yield
- BRAG N/A
- SLGL N/A
- EPS Growth
- BRAG N/A
- SLGL N/A
- EPS
- BRAG N/A
- SLGL N/A
- Revenue
- BRAG $123,209,630.00
- SLGL $23,931,000.00
- Revenue This Year
- BRAG $6.62
- SLGL N/A
- Revenue Next Year
- BRAG $5.85
- SLGL $31.17
- P/E Ratio
- BRAG N/A
- SLGL N/A
- Revenue Growth
- BRAG 10.90
- SLGL 264.86
- 52 Week Low
- BRAG $2.59
- SLGL $4.01
- 52 Week High
- BRAG $6.12
- SLGL $52.26
- Technical
- Relative Strength Index (RSI)
- BRAG 48.52
- SLGL 67.60
- Support Level
- BRAG $2.80
- SLGL $34.80
- Resistance Level
- BRAG $2.95
- SLGL $52.26
- Average True Range (ATR)
- BRAG 0.15
- SLGL 4.38
- MACD
- BRAG 0.03
- SLGL 0.93
- Stochastic Oscillator
- BRAG 45.61
- SLGL 47.70
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.